Abstract: The present invention relates to different forms of a HCV inhibitory compound.

Abstract: A display device properly corrects chromaticity of display images with achieving high brightness. A liquid crystal display device 10 includes a liquid crystal panel 11 and a backlight unit 12. The liquid crystal display device 10 includes a pair of boards 11a, 11b and a liquid crystal layer 11c formed of liquid crystals that change their optical characteristics by implication of an electric field. The backlight unit 12 exits light toward the liquid crystal panel 11. One of the boards 11a, 11b of the liquid crystal panel 11 includes a color filter 19 including color portions R, G, B, Y each in red, green, blue, yellow. The backlight unit 12 includes LEDs 24 as a light source and each of the LEDs includes an LED chip 24a as a light emission source and a phosphor that is excited by light from the LED chip 24a and emits light. The phosphor includes at least a YAG-based phosphor.

Abstract: A multiple depth display provided for displaying images at different depths comprises a single display device (61), for displaying all of the images. An optical system (62, 63, 64) is disposed in front of the display device (61). The optical system comprises first and second spaced-apart partial reflectors (62, 63) and polarization optics (64) for providing first and second light paths for first and second images or sequences of images displayed by the device (61). The first light path (65) comprises partial transmission through the first reflector (62), partial reflection from the second reflector (63), partial reflection from the first reflector (62), and partial transmission through the second reflector (65) towards a viewing region.

Abstract: A scan signal line drive circuit (32) for driving switching elements is provided in a frame area (24) of an active matrix substrate (20). A driver TFT element (42) is provided in each circuit section (36) which is part of a scan signal line drive circuit (32). The frame area (24) has a branch line (43) as a second line for supplying a signal to the driver TFT element (42) and a connecting line (44) as a first line connected to the branch line (43). The connecting line (44) and the branch line (43) are connected to each other in a connecting section (60). Both of the sides of the branch line (43), which specify the width of the branch line (43), are disposed in a contact hole (61) in planar view, the contact hole (61) being provided in a second insulating layer.

Abstract: Provided are (i) a touch panel substrate improved in uniformity of in-plane light transmittance and (ii) an electronic device employing the touch panel substrate. First sensor electrodes (11) are arranged in a first electrode layer (10), and second electrodes are arranged in a second electrode layer. In part of an outer edge of a first sensor electrode (11) which part is arranged side by side with an outer edge of a second electrode when viewed from above, ends of conductor lines (13) of the first sensor electrode (11) have respective wide width parts (40) each of which is wider than the other part of the conductor lines (13) when viewed from above.

Abstract: The present invention provides a touch panel substrate that allows for greater design freedom when designing conductive wire patterns for reducing occurrence of the moiré effect. The touch panel substrate includes: a first electrode layer that includes first conductive wires and second conductive wires; and a second electrode layer that includes third conductive wires and fourth conductive wires. When viewed in a plan view, the first conductive wires and the third conductive wires form first quadrilaterals, and the second conductive wires and the fourth conductive wire form second quadrilaterals. The first quadrilaterals and the second quadrilaterals are not identical to one another.

Abstract: This light diffusion member includes: a substrate having light transmissivity; a plurality of light shielding layers formed on one face of the substrate; and light diffusion portions formed on the one face of the substrate at regions other than the regions where the light shielding layers have been formed. The light diffusion portions have a light-emitting end surface coming into contact with the substrate, a light incident end surface which faces the light-emitting end surface and has a larger area than the area of the light-emitting end surface, and a reflecting face coming into contact with the light-emitting end surface and the light incident end surface, and reflecting light entering from the light incident end surface. The height from the light incident end surface to the light-emitting end surface of the light diffusion portion is greater than the thickness of the light shielding layers.

Abstract: The present invention is directed to 2-pyridyloxy-4-ether compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the 2-pyridyloxy-4-ether compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

Abstract: The present invention is a sensor for detecting a microorganism, which is provided with a detection unit equipped with a detection electrode and a polymer layer, wherein the polymer layer is arranged on the detection electrode and is provided with a template having a three-dimensional structure complementary to a three-dimensional structure of a microorganism to be detected. The sensor detects a microorganism on the basis of the captured state of the microorganism onto the template. The polymer layer is formed by a manufacturing method including a polymerization step of polymerizing a monomer in the presence of the microorganism to be detected to form a polymer layer having the microorganism incorporated therein on the detection electrode, and a disruption step of bringing at least a part of the microorganism incorporated in the polymer layer into contact with a solution containing a lytic enzyme to disrupt the microorganism.

Abstract: A terminal device that is capable of increasing the number of spatial multiplexes of a reference signal is provided. A terminal device according to the present invention is a terminal device that generates and transmits a reference signal. The terminal device includes a reference signal generation module that configures a repetition factor (RF) of the reference signal based on a signal which is notified by a base station, and generates the reference signal. Furthermore, the reference signal generation module uses at least one among multiple values that are included in the signal which is notified by the base station, only for configuration of the RF.

Abstract: In its many embodiments, the present invention provides certain C2-azaspiro substituted iminothiazine dioxide compounds. The novel compounds of the invention are useful as BACE inhibitors and/or for the treatment and prevention of various pathologies related thereto. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use, including for the possible treatment of Alzheimer's disease, are also disclosed.

Abstract: There is provided a base station including a downlink channel generator, a reference signal generator, and a transmitter. The downlink channel generator generates a downlink channel for a terminal. The reference signal generator generates a first demodulation reference signal or a second demodulation reference signal which is a demodulation reference signal associated with the downlink channel and is enabled to be multiplexed between a plurality of antenna ports. The transmitter transmits the downlink channel and transmits the first demodulation reference signal or the second demodulation reference signal selected based on a configuration for the terminal. Granularity of the first demodulation reference signal is different from granularity of the second demodulation reference signal in a resource block.

Abstract: According to one aspect of the present invention, there is provided a wireless communication device that transmits a first wireless signal representing a bit sequence to a reception device, in which the first wireless signal is transmitted concurrently with a second wireless signal representing the bit sequence described above, and in which between the first wireless signal and the second wireless signal, components with a prescribed ratio are mapped to a different frequency or to a different time between the first wireless signal and the second wireless signal and remaining components are mapped to the same frequency and to the same time between the first wireless signal and the second wireless signal.

Abstract: The present invention is directed to substituted pyridizinone compounds of formula I which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

Abstract: An image forming apparatus including a near field communication unit configured to make a short-range wireless communication with a portable information processing device including a display unit and a control unit, the control unit including: a recognition unit configured to recognize a portable information processing device that is within a communicable range through communication via the near field communication unit; a job setting unit configured to transmit data for displaying and activating a job setting screen on the display unit of the recognized portable information processing device, via the near field communication unit; and a job control unit configured to execute a job in response to a start instruction of the job, wherein the job setting unit receives a job setting, which is made by using the job setting screen, via the near field communication unit after the recognition to receive the job setting from the portable information processing device, and the job control unit receives a start instruct

Abstract: An antenna element (10) includes: a feeding point (16); a connector (15) in which an external antenna is detachably engaged; a first partial element (11) connecting the feeding point (16) and the connector (15); and a second partial element (12) branching from the first partial element (11) and having an open end (12a) at a different position from the connector (15).

Abstract: There is provided a terminal (200) which communicates with a base station by using a resource element constituted by a sub-carrier and an OFDM symbol. The terminal includes a receiver (201), an uplink channel generator (241), and a transmitter (242). The receiver (201) receives a CSI reference signal transmitted from the base station. The uplink channel generator (241) generates an uplink channel including a first feedback information or a second feedback information which is feedback information generated by using the CSI reference signal, and is selected based on a configuration for the terminal. The transmitter (242) transmits the uplink channel to the base station. The first feedback information and the second feedback information are generated for a PDSCH which is assumed to be different from each other, in a CSI reference resource.

Abstract: In its many embodiments, the present invention provides certain S-imino-S-oxo iminothiadiazine compounds, including compounds Formula (I): or a tautomers and/or stereoisomers thereof, and pharmaceutically acceptable salts of said compounds, said tautomeros and said stereoisomers, wherein RN, R1, R2, R3, R4, ring A, RA, m, L1, and RL are as defined herein. The novel compounds of the invention are useful as BACE inhibitors and may be useful for the treatment and prevention of various pathologies related thereto. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use, including for the possible treatment of Alzheimer's disease, are also disclosed.

Abstract: The present invention provides, inter alia, an isolated cell line, 3M as well as methods for making such a cell line and methods of using such a cell line, e.g., to produce a protein such as an immunoglobulin.

Abstract: In its many embodiments, the present invention provides certain S-imino-S-oxo iminothiazine compounds, including compounds Formula (I): or a tautomers and/or stereoisomers thereof, and pharmaceutically acceptable salts of said compounds, said tautomeros and said stereoisomers, wherein RN, R1A, R1B, R2, R3, R4, ring A, RA, m, L1-, and RL are as defined herein. The novel compounds of the invention are useful as BACE inhibitors and may be useful for the treatment and prevention of various pathologies related thereto. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use, including for the possible treatment of Alzheimer's disease, are also disclosed.